• Home
  • Search
  • Insulin Pump Class: Back to the Basics of Pump Therapy.
  • Cite Icon6
  • https://doi.org/10.2337/diaspect.27.2.135Copy DOI Icon

Insulin Pump Class: Back to the Basics of Pump Therapy.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

In the early 1960s, Dr. Arnold Kadish developed the first insulin pump, which was the size of a Marine backpack.1 Over the years, insulin pumps have become much more refined and have decreased in bulk to the size and weight of a small pager. Insulin pump therapy, also known as continuous subcutaneous insulin infusion, is no longer seen as experimental and controversial, but rather is viewed as an acceptable alternative to multiple daily injection (MDI) therapy in the management of insulin-dependent diabetes2 (Table 1).3 The insulin pump is an electromechanical device that mimics the body's natural insulin secretion from pancreatic β-cells by subcutaneously delivering rapid-acting insulin both at preset continuous basal rates and in extra bolus doses at mealtimes on demand.4 Insulin pumps allow for up to 24 different hourly basal rates in a 24-hour period. For bolus doses, pump users input their current blood glucose level and the number of carbohydrates they will consume, and the pump customizes their dose based on insulin currently on board (i.e., the remaining active insulin from the previous dose), their individualized insulin-to-carbohydrate ratio, and their individualized insulin sensitivity factor (i.e., their expected drop in blood glucose from 1 unit of insulin).1,5 Thus, insulin pumps are able to deliver insulin in a more physiological manner than other injection-based insulin regimens.5 In the late 1970s, results of the first human trials of insulin pump therapy were published. This was followed by numerous additional studies comparing insulin pump therapy to traditional MDI regimens with regard to long-term glycemic control and minimization of hypoglycemia.6–11 Then, in 1993, the Diabetes Control and Complications Trial12 confirmed the importance of intensive glycemic control using either insulin pump therapy or an MDI regimen along with frequent self-monitoring of …

Similar Papers
  • Research Article
  • Citations22

Type 1 Diabetes Mellitus

  • May 01, 2013
  • Pediatrics In Review
  • Justin M Gregory +2
  • Research Article
  • Citations4

Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy

  • Jan 01, 2019
  • Acta Bio Medica : Atenei Parmensis
  • Fawzia Alyafie +6
  • PDF
  • Research Article
  • Citations336

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

  • Feb 01, 2010
  • Health technology assessment (Winchester, England)
  • E Cummins +6
  • Research Article
  • Citations37

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: Insulin pump therapy versus multiple daily injections

  • Jan 01, 2007
  • Clinical Therapeutics
  • Bruce W Bode
  • Research Article
  • Citations5

Systematic review and meta-analysis of insulin pump therapy in children and adolescents with type 1 diabetes

  • Apr 01, 2010
  • Archives of Disease in Childhood
  • J Gane +3
  • Research Article

Access to insulin pump therapy and continuous glucose monitoring - is it an even playing field?

  • Jul 15, 2012
  • Diabetic Medicine
  • G A Hitman
  • Research Article
  • Citations2

Comparison of Continuous Subcutaneous Insulin Infusion versus Basal/Bolus Insulin Injections for Treatment of Type 1 Diabetes in Clinical Practice

  • Mar 01, 2009
  • Journal of Diabetes Science and Technology
  • Anjana Myneni +5
  • Research Article
  • Citations39

Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: a review of one institution's experience.

  • Nov 01, 2008
  • Journal of Diabetes Science and Technology
  • Brenda J Leonhardi +8
  • Research Article
  • Citations62

Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial.

  • Sep 08, 2015
  • Diabetic Medicine
  • J Lawton +7
  • Research Article
  • Citations34

Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience.

  • May 01, 2007
  • Journal of Diabetes Science and Technology
  • Scott W Lee +7
  • Research Article

The Impact of Insulin Pump Therapy on Glycemic Control and Acute Diabetes Complications in Type 1 Diabetes: Real-World Evidence From a Single Center

  • Sep 01, 2025
  • Cureus
  • Osama Saad Bindajam +9
  • Research Article
  • Citations21

Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems

  • Apr 21, 2014
  • Expert Opinion on Drug Delivery
  • Martin Tauschmann +1
  • Research Article
  • Citations178

Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus

  • Oct 01, 2002
  • The Journal of Pediatrics
  • Jean Litton +5
  • Research Article
  • Citations12

Use and Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Multiple Daily Insulin Injection Therapy (MIT) in Children, Adolescents and Young Adults with Type 1 Diabetes Mellitus.

  • Feb 19, 2016
  • Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
  • R Schiel +5
  • Research Article
  • Citations41

Point: Are Insulin Pumps Underutilized in Type 1 Diabetes? Yes

  • May 26, 2006
  • Diabetes Care
  • John C Pickup
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.